YH29407 with anti-PD-1 ameliorates anti-tumor effects via increased T cell functionality and antigen presenting machinery in the tumor microenvironmentDong Kwon Kim, Byoung Chul Cho|Frontiers in Chemistry|2022Cited by 4
Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with PembrolizumabDong Kwon Kim, Byoung Chul Cho|Molecular Cancer Therapeutics|2024Cited by 3